We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$147B
1-Year Est. Return
18.73%
This Fund
S&P 500
This Quarter
Est. Return
+7.05%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$131B
AUM Growth
+$13.8B
(+12%)
Cap. Flow
+$6.04B
Cap. Flow
% of AUM
4.61%
Top 10 Holdings %
Top 10 Hldgs %
44.72%
Holding
4,042
New
364
Increased
2,601
Reduced
814
Closed
133
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$740M |
| 2 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$544M |
| 3 |
NVIDIA
NVDA
|
+$407M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$325M |
| 5 |
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
|
+$276M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$232M |
| 2 |
Vanguard Large-Cap ETF
VV
|
+$58.3M |
| 3 |
Vanguard Total Stock Market ETF
VTI
|
+$46.4M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$40M |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$37.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.26% |
| 2 | Financials | 3.77% |
| 3 | Consumer Discretionary | 2.12% |
| 4 | Communication Services | 1.89% |
| 5 | Healthcare | 1.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3701
Cardiff Oncology
CRDF
$64.3M
| $82.6K | ﹤0.01% |
40,102
+6,052
| +18% | +$16.7K |
|
3702
Eve Holding
EVEX
$798M
| $82.5K | ﹤0.01% |
+21,657
| New | +$115K |
|
3703
Standard BioTools
LAB
$326M
| $81.9K | ﹤0.01% |
62,996
+1,894
| +3% | +$2.48K |
|
3704
Personalis
PSNL
$1.26B
| $81.9K | ﹤0.01% |
+12,558
| New | +$71.5K |
|
3705
Quad
QUAD
$430M
| $80.8K | ﹤0.01% |
12,903
+715
| +6% | +$4.41K |
|
|
EMX
3706
DELISTED
EMX Royalty
EMX
| $80.5K | ﹤0.01% |
15,637
+1,270
| +9% | +$4.39K |
|
3707
TMC The Metals Company
TMC
$1.59B
| $77.1K | ﹤0.01% |
12,106
+630
| +5% | +$3.78K |
|
3708
Humacyte
HUMA
$168M
| $76.6K | ﹤0.01% |
+44,012
| New | +$86.2K |
|
|
AEF
3709
abrdn Emerging Markets Equity Income Fund
AEF
$348M
| $76K | ﹤0.01% |
11,733
| – | – |
|
|
MGRM
3710
DELISTED
Monogram Orthopaedics
MGRM
| $75.2K | ﹤0.01% |
+12,814
| New | +$68.4K |
|
3711
Surf Air Mobility
SRFM
$87.8M
| $74.8K | ﹤0.01% |
+17,440
| New | +$81.7K |
|
|
EAD
3712
Allspring Income Opportunities Fund
EAD
$372M
| $74.6K | ﹤0.01% |
+10,644
| New | +$75.2K |
|
3713
IHS Holding
IHS
$2.77B
| $74.2K | ﹤0.01% |
10,877
-2,992
| -22% | -$20K |
|
3714
ProFrac Holding
ACDC
$771M
| $74.1K | ﹤0.01% |
20,026
+6,906
| +53% | +$38K |
|
3715
Riverview Bancorp
RVSB
$107M
| $73.6K | ﹤0.01% |
13,711
+2,566
| +23% | +$13.3K |
|
3716
Rackspace Technology
RXT
$1B
| $72.7K | ﹤0.01% |
51,566
+25,851
| +101% | +$34.6K |
|
|
GGN
3717
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$767M
| $71.8K | ﹤0.01% |
13,931
-2,000
| -13% | -$9.35K |
|
|
BDN
3718
Brandywine Realty Trust
BDN
$551M
| $70.6K | ﹤0.01% |
16,923
+2,679
| +19% | +$11.3K |
|
3719
Atea Pharmaceuticals
AVIR
$379M
| $69.8K | ﹤0.01% |
24,062
+1,721
| +8% | +$5.88K |
|
3720
Clover Health Investments
CLOV
$2.28B
| $69.8K | ﹤0.01% |
22,796
+11,644
| +104% | +$33.3K |
|
3721
Nano X Imaging
NNOX
$62.4M
| $69.3K | ﹤0.01% |
18,742
-87,567
| -82% | -$390K |
|
3722
Safe Bulkers
SB
$781M
| $68.6K | ﹤0.01% |
15,450
+3,133
| +25% | +$13.3K |
|
3723
Claros Mortgage Trust
CMTG
$306M
| $68.6K | ﹤0.01% |
+20,648
| New | +$69.5K |
|
|
ODV
3724
DELISTED
Osisko Development Corp
ODV
| $68.5K | ﹤0.01% |
+20,213
| New | +$53.6K |
|
3725
FerroAtlántica
GSM
$628M
| $68K | ﹤0.01% |
14,947
+3,344
| +29% | +$14.3K |
|
Similar funds
Creative Planning's Q3 2025 Portfolio in Review
As of Q3 2025, Creative Planning held 4,042 positions worth $131B, up 12% from $117B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Creative Planning deployed $6.04B of net new capital in Q3 2025, opening 364 new positions and adding to 2,601 existing holdings. Its largest new stake was Amrize Ltd: 170,878 shares worth $8.29M.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, up from 7% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $232M trimmed.
- Creative Planning's largest Q3 2025 buy was Amrize Ltd: 170,878 shares worth $8.29M.
- Creative Planning added most to Vanguard Total Bond Market in Q3 2025, an estimated $740M increase.
- Creative Planning's biggest Q3 2025 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $232M.
- Creative Planning fully exited Ansys in Q3 2025, selling an estimated $4.86M.
- Creative Planning's ten largest holdings make up 45% of its $131B portfolio in Q3 2025.
- Creative Planning opened 364 new positions and closed 133 in Q3 2025.
- Creative Planning's portfolio value rose 12% quarter-over-quarter to $131B.
Based on Creative Planning's 13F filing for Q3 2025, filed 14 Nov 2025.